Brainsway
Jerusalem, US · Israel corporation
BrainsWay is a medical technology company that develops Deep Transcranial Magnetic Stimulation (Deep TMS) devices, an FDA-cleared noninvasive treatment for mental health conditions including depression, anxious depression, OCD, and smoking addiction. Its devices are used by mental health providers and healthcare partners to treat patients, including treatment-resistant cases.
BiotechDigital HealthMedical DevicesMental Health
Founders & leadership
HL

Hadar LevyChief Executive Officer
IM
Ido MaromChief Financial Officer
AZ
Abraham ZangenNamed on SEC filing
Board
YB
Yossi Ben ShalomBoard director
AH
Avner HagaiBoard director
DZ
David ZacutVice Chairman of the Board of Directors
EM
Eti MitranyBoard director
KS
Karen SaridBoard director
AB
Ami BoehmChairman of the Board of Directors
AL
Avner LushiBoard director
Reported raises · per SEC filings
Form D private placements$20M disclosed across 1 round · 2024
▶$20MraisedOct 2024 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedOct 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hadar LevyExecutive Officer
- Yossi Ben ShalomDirector
- Avner HagaiDirector
- David ZacutDirector
- Ido MaromExecutive Officer
- Abraham ZangenDirector
- Eti MitranyDirector
- Karen SaridDirector
- Ami BoehmDirector
- Avner LushiDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Sep 2024
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Brainsway for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Brainsway do?
- BrainsWay is a medical technology company that develops Deep Transcranial Magnetic Stimulation (Deep TMS) devices, an FDA-cleared noninvasive treatment for mental health conditions including depression, anxious depression, OCD, and smoking addiction. Its devices are used by mental health providers and healthcare partners to treat patients, including treatment-resistant cases.
- How much funding has Brainsway raised?
- Brainsway has disclosed $20M raised across 1 round.
- Where is Brainsway headquartered?
- Brainsway is headquartered in Jerusalem, US.